Veritas In Silico Inc.

¥266.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:130AHealthcare
Country Japan
PE (Fwd) •••
TSR 3Y CAGR (54.80%)
Div yield —
ROE (36.69%)
Biotechnology
Beta (5Y) (0.14)
PE TTM —
TSR TTM (51.99%)
Mkt cap ¥1.726B
ROIC (16.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥302
13.50%
90.78%
Hold 12|10|2|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
3.18
3.16
3.50
3.84
1.62%
(0.28%)
12.94%
23.26%
Revenue¥M
91.37
91.56
89.38
86.92
0.42%
(1.48%)
(2.55%)
(2.47%)
Peers (US$10.96M)
Cap (US$)
PE
10.99M
—
Capital
TTM
5Y
10Y
Leveragex
0.823
0.924
0.670
EBIT/Intx
0.664
0.464
0.462
Own earn%
(123.18)
(70.37)
(59.84)
Sh yield%
27.49
33.77
32.90
Owners
Insiders/Inst%
4.01
86.48
Short interest%
4.78
SBC / revenue%
4.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
7–11
$1 testx
—
Incr. ROIC%
6